CD8 T-cell proliferative capacity is compromised in primary HIV-1 infection

Journal of Acquired Immune Deficiency Syndromes

Volumn 56, Issue 3, 2011, Pages 213-221

  Heath, Sonya L ^a   Sabbaj, Steffanie ^a   Bansal, Anju ^a   Kilby, J Michael ^b   Goepfert, Paul A ^a,c  

^a University of Alabama at Birmingham   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c University of Alabama at Birmingham   (United States)

Author keywords

acute HIV infection; CD8+ T cells; interleukin 2; polyfunctional; primary HIV infection; T cell proliferation

Indexed keywords

EPITOPE; INTERLEUKIN 2;

ARTICLE; BLOOD SAMPLING; BYSTANDER EFFECT; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL POPULATION; CELL PROLIFERATION; CORRELATION ANALYSIS; CYTOKINE RELEASE; CYTOTOXIC T LYMPHOCYTE; FLOW CYTOMETRY; HLA TYPING; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMUNITY; INFECTION CONTROL; LYMPHOCYTE COUNT; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; VIRUS ENTRY; VIRUS LOAD;

CD8-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; HIV INFECTIONS; HIV-1; HUMANS; INTERLEUKIN-2; LYMPHOCYTE SUBSETS;

EID: 79951812133     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAI.0b013e3181ff2aba     Document Type: Article

References (41)

1. Daar ES, Moudgil T, Meyer RD, et al. Transient high levels of viremia in patients with primary human immunodeficiency virus type 1 infection. N Engl J Med. 1991;324:961-964.
2. Clark SJ, Saag MS, Decker WD, et al. High titers of cytopathic virus in plasma of patients with symptomatic primary HIV-1 infection. N Engl J Med. 1991;324:954-960.
3. Boasso A, Shearer GM. Chronic innate immune activation as a cause of HIV-1 immunopathogenesis. Clin Immunol. 2008;126:235-242. (Pubitemid 351221427)
4. Douek D. HIV disease progression: immune activation, microbes, and a leaky gut. Top HIV Med. 2007;15:114-117.
5. Veazey RS, DeMaria M, Chalifoux LV, et al. Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection. Science. 1998;280:427-431. (Pubitemid 28208163)
6. Brenchley JM, Price DA, Schacker TW, et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med. 2006;12:1365-1371. (Pubitemid 44924494)
7. Brenchley JM, Schacker TW, Ruff LE, et al. CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. J Exp Med. 2004;200:749-759. (Pubitemid 39299461)
8. Koup RA, Safrit JT, Cao Y, et al. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J Virol. 1994;68:4650-4655. (Pubitemid 24183063)
9. Jin X, Bauer DE, Tuttleton SE, et al. Dramatic rise in plasma viremia after CD8(+) T cell depletion in simian immunodeficiency virus-infected macaques. J Exp Med. 1999;189:991-998. (Pubitemid 29149355)
10. Almeida JR, Price DA, Papagno L, et al. Superior control of HIV-1 replication by CD8+ T cells is reflected by their avidity, polyfunctionality, and clonal turnover. J Exp Med. 2007;204:2473-2485. (Pubitemid 47529331)
11. Betts MR, Nason MC, West SM, et al. HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells. Blood. 2006;107: 4781-4789. (Pubitemid 43882629)
12. Migueles SA, Laborico AC, Shupert WL, et al. HIV-specific CD8+ T cell proliferation is coupled to perforin expression and is maintained in nonprogressors. Nat Immunol. 2002;3:1061-1068. (Pubitemid 35363659)
13. Horton H, Frank I, Baydo R, et al. Preservation of T cell proliferation restricted by protective HLA alleles is critical for immune control of HIV-1 infection. J Immunol. 2006;177:7406-7415. (Pubitemid 44715111)
14. Jagannathan P, Osborne CM, Royce C, et al. Comparisons of CD8+ T cells specific for human immunodeficiency virus, hepatitis C virus, and cytomegalovirus reveal differences in frequency, immunodominance, phenotype, and interleukin-2 responsiveness. J Virol. 2009;83:2728-2742.
15. Benito JM, Lopez M, Soriano V. The role of CD8+ T-cell response in HIV infection. AIDS Rev. 2004;6:79-88. (Pubitemid 39149446)
16. Day CL, Kiepiela P, Leslie AJ, et al. Proliferative capacity of epitopespecific CD8 T-cell responses is inversely related to viral load in chronic human immunodeficiency virus type 1 infection. J Virol. 2007;81: 434-438. (Pubitemid 44975185)
17. Betts MR, Ambrozak DR, Douek DC, et al. Analysis of total human immunodeficiency virus (HIV)-specific CD4(+) and CD8(+) T-cell responses: relationship to viral load in untreated HIV infection. J Virol. 2001;75:11983-11991. (Pubitemid 33115870)
18. Lichterfeld M, Kaufmann DE, Yu XG, et al. Loss of HIV-1-specific CD8+ T cell proliferation after acute HIV-1 infection and restoration by vaccineinduced HIV-1-specific CD4+ T cells. J Exp Med. 2004;200:701-712. (Pubitemid 39299457)
19. Zimmerli SC, Harari A, Cellerai C, et al. HIV-1-specific IFN-gamma/IL- 2-secreting CD8 T cells support CD4-independent proliferation of HIV-1- specific CD8 T cells. Proc Natl Acad Sci USA. 2005;102:7239-7244. (Pubitemid 40696363)
20. Kilby JM, Lee HY, Hazelwood JD, et al. Treatment response in acute/early infection versus advanced AIDS: equivalent first and second phases of HIV RNA decline. AIDS. 2008;22:957-962. (Pubitemid 351652246)
21. Edwards BH, Bansal A, Sabbaj S, et al. Magnitude of functional CD8+ Tcell responses to the gag protein of human immunodeficiency virus type 1 correlates inversely with viral load in plasma. J Virol. 2002;76:2298-2305. (Pubitemid 34150698)
22. Bansal A, Gough E, Sabbaj S, et al. CD8 T-cell responses in early HIV-1 infection are skewed towards high entropy peptides. AIDS. 2005;19: 241-250. (Pubitemid 40396555)
23. Fuller MJ, Hildeman DA, Sabbaj S, et al. Cutting edge: emergence of CD127high functionally competent memory T cells is compromised by high viral loads and inadequate T cell help. J Immunol. 2005;174: 5926-5930. (Pubitemid 40663777)
24. Sabbaj S, Heath SL, Bansal A, et al. Functionally competent antigenspecific CD127(hi) memory CD8+ T cells are preserved only in HIVinfected individuals receiving early treatment. J Infect Dis. 2007;195: 108-117. (Pubitemid 44958232)
25. Saez-Cirion A, Sinet M, Shin SY, et al. Heterogeneity in HIV suppression by CD8 T cells from HIV controllers: association with Gag-specific CD8 T cell responses. J Immunol. 2009;182:7828-7837.
26. Calarota SA, Foli A, Maserati R, et al. HIV-1-specific T cell precursors with high proliferative capacity correlate with low viremia and high CD4 counts in untreated individuals. J Immunol. 2008;180:5907-5915.
27. Kan-Mitchell J, Bisikirska B, Wong-Staal F, et al. The HIV-1 HLA-A2- SLYNTVATL is a help-independent CTL epitope. J Immunol. 2004;172: 5249-5261. (Pubitemid 38542022)
28. Sun JC, Bevan MJ. Defective CD8 T cell memory following acute infection without CD4 T cell help. Science. 2003;300:339-342. (Pubitemid 36433727)
29. Mehandru S, Poles MA, Tenner-Racz K, et al. Primary HIV-1 infection is associated with preferential depletion of CD4+ T lymphocytes from effector sites in the gastrointestinal tract. J Exp Med. 2004;200:761-770. (Pubitemid 39299462)
30. Turnbull EL, Wong M, Wang S, et al. Kinetics of expansion of epitopespecific T cell responses during primary HIV-1 infection. J Immunol. 2009;182:7131-7145.
31. Brockman MA, Kwon DS, Tighe DP, et al. IL-10 is up-regulated in multiple cell types during viremic HIV infection and reversibly inhibits virus-specific T cells. Blood. 2009;114:346-356.
32. Yu J, Chen H, Horton H, et al. Interleukin-2 reconstitutes defective human immunodeficiency virus (HIV), and cytomegalovirus (CMV) specific CD8+ T cell proliferation in HIV infection. J Med Virol. 2006;78: 1147-1157. (Pubitemid 44182230)
33. Iyasere C, Tilton JC, Johnson AJ, et al. Diminished proliferation of human immunodeficiency virus-specific CD4+ T cells is associated with diminished interleukin-2 (IL-2) production and is recovered by exogenous IL-2. J Virol. 2003;77:10900-10909. (Pubitemid 37204283)
34. Migueles SA, Weeks KA, Nou E, et al. Defective human immunode- ficiency virus-specific CD8+ T-cell polyfunctionality, proliferation, and cytotoxicity are not restored by antiretroviral therapy. J Virol. 2009;83: 11876-11889.
35. Abrams D, Levy Y, Losso MH, et al. Interleukin-2 therapy in patients with HIV infection. N Engl J Med 2009;361:1548-1559.
36. Chopra RK, Raj NB, Scally JP, et al. Relationship between IL-2 receptor expression and proliferative responses in lymphocytes from HIV-1 seropositive homosexual men. Clin Exp Immunol. 1993;91:18-24. (Pubitemid 23027991)
37. Makedonas G, Hutnick N, Haney D, et al. Perforin and IL-2 upregulation define qualitative differences among highly functional virus-specific human CD8 T cells. PLoS Pathog. 2010;6:e1000798.
38. Hersperger AR, Pereyra F, Nason M, et al. Perforin expression directly ex vivo by HIV-specific CD8 T-cells is a correlate of HIV elite control. PLoS Pathog. 2010;6:e1000917.
39. Crawford A, Macleod M, Schumacher T, et al. Primary T cell expansion and differentiation in vivo requires antigen presentation by B cells. J Immunol. 2006;176:3498-3506. (Pubitemid 43363997)
40. Fantuzzi L, Belardelli F, Gessani S. Monocyte/macrophage-derived CC chemokines and their modulation by HIV-1 and cytokines: a complex network of interactions influencing viral replication and AIDS pathogenesis. J Leukoc Biol. 2003;74:719-725. (Pubitemid 38040348)
41. Estes JD, Harris LD, Klatt NR, et al. Damaged intestinal epithelial integrity linked to microbial translocation in pathogenic simian immunodeficiency virus infections. PLoS Pathog. 2010;6(8). pii:e1001052.